Assembled from the company's filings and exchange data as of today. Download PDF renders this page on the server; the narrative sections arrive with the Nexa composer.
Dossier · KANORIACHEMICALS- · 9 October 2026Page 1 of 3
Company Dossier
MarketPing Research · factual · no rating expressed
KANORIACHEMICALS-
NSE: KANORICHEM · BSE: 506525

KANORIACHEMICALS-

StateQ1 FY27 filed
Last close · 8 Oct 2026₹177.50
Market cap₹0.8k cr
TTM P/E · P/B · EV/EBITDA5.0 · 1.35 · 8.3

KANORIACHEMICALS- is a listed company listed on NSE. The annual-report business brief for this company has not been generated yet; the numbers below are as filed.

What a broker report prints here — the analyst's thesis. This dossier prints the filed record instead; the narrative read of the latest results, the guidance ledger and the earnings-call summary are the composer's sections (INSTITUTIONAL-PLAN.md M3) and are not yet produced.

Exhibit 1: Financial summary, FY22–FY26 (all audited; no estimate years)

₹ crore · consolidatedFY22FY23FY24FY25FY26
Revenue1,3691,5781,4771,537981
EBITDA (ex other income)687250271
margin %5.04.63.40.17.3
Owners' profit79(34)(75)151
EPS, as reported (₹)1.56(2.01)(8.79)(19.13)27.64
ROE % · ROCE %0.4 · 4.0(2.1) · 2.4(9.0) · 0.7(21.2) · (5.6)19.8 · 7.3
Debt / equity (x)0.780.840.821.160.51
Cash from operations8326382066
Capex(43)(57)(81)(100)(88)
Source: SEBI results XBRL as filed with BSE/NSE; EBITDA excludes other income.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · KANORIACHEMICALS- · 9 October 2026Page 2 of 3

Exhibit 2: Quarterly performance, last 8 quarters

₹ croreQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue374348431454210266304460
Profit before tax(9)(27)(38)(10)161735
Net profit(16)(29)(40)(14)9243226
EPS (₹)(3.18)(3.82)(8.33)(1.79)21.380.817.246.03
Source: quarterly results as filed; the balance sheet is filed half-yearly and is not repeated here.

Exhibit 3: Segment revenue, FY26

SegmentRevenue, ₹ croreShare %
ALCO CHEMICALS49840.4
TEXTILE1068.6
CHEMICALS37730.6
ELECTRONIC AUTOMOTIVE25220.5
Total, before eliminations1,234100.0
Source: the filed segment block, four quarters summed.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · KANORIACHEMICALS- · 9 October 2026Page 3 of 3

Exhibit 4: Filings of the last 90 days, with the measured price reaction

Date · filingCategoryImportance1-day %5-day %
8 Oct 2026 · Quarterly compliance certificate under SEBI Regulation 74(5) for Q2 FY26-27complianceminimal——
7 Oct 2026 · KCI launches new 12 TPD Triacetin facility at Ankleshwarcapex operationshigh——
7 Oct 2026 · Kanoria Chemicals gets IVR BBB-/Stable and A3 credit ratings from Infomericscredit debtmedium——
21 Sept 2026 · Trading Window Closes Oct 1 Ahead of Q2 FY26 Resultscomplianceminimal——
3 Sept 2026 · Kanoria Chemicals 66th AGM: All 4 resolutions passed with over 99.99% majoritycomplianceminimal——
2 Sept 2026 · Kanoria Chemicals AGM FY26: revenue up 29%, EBITDA margin to 9.3%, net profit turnaroundinvestor communicationsmedium——
2 Sept 2026 · 66th AGM Held: Financials Adopted, Director Re-appointments Approvedboard shareholder meetingslow——
12 Aug 2026 · Newspaper publication of Q1 FY27 unaudited financial resultscomplianceminimal——
11 Aug 2026 · Q1 FY27: Revenue jumps 130 percent YoY to Rs 430 cr, PAT swings to Rs 26.4 cr profitresultshigh——
11 Aug 2026 · Kanoria Chemicals Q1 FY27 results: revenue up 130%, PAT turns positive at Rs 26.4 crresultshigh——
Source: exchange announcements; reaction = close-to-close from the filing's session.

How to read this document

Where a broker report showsThis document showsWhy
A rating (BUY / ADD / REDUCE / SELL)A state: the latest filed quarter and the measured reactionsan event is a fact; a rating is an opinion that requires SEBI RA registration
A target price and upsideThe current price and the multiples against the groupa target is a forecast; a multiple is a measurement
Estimate years marked EMore audited years; no estimatesMarketPing publishes no forecasts — your own model lives on the Models page

Sources, method and disclosures

This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.

Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in